Mukherjee, Devashis
Coffey, Mary
Maisels, M. Jeffrey
Article History
Received: 20 February 2018
Revised: 18 April 2018
Accepted: 17 May 2018
First Online: 19 June 2018
Compliance with ethical standards
:
: MJM is a consultant to Mallinckrodt Pharmaceuticals, the current marketer of tin-mesoporphyrin (Stannate), a drug that has been used in the treatment and prevention of hyperbilirubinemia but is currently not approved by the FDA. D.M. and M.C. declare that they have no conflict of interest.